ryanmthomas

ryanmthomas

About Ryan M. Thomas

This author has not yet filled in any details.
So far Ryan M. Thomas has created 28 blog entries.

Eyam Announces Partnership with Mitacs to Fund Next Generation COVID-19 Vaccine Technologies

By |2022-10-11T16:06:51+00:00October 11th, 2022|News|

Over the last several months, it seems like we’ve been on a COVID-19 Rollercoaster. First, the long-awaited vaccines rolled out and a subsequent decline in cases was reported in regions where vaccines were rolled out quickly.

Comments Off on Eyam Announces Partnership with Mitacs to Fund Next Generation COVID-19 Vaccine Technologies

Vaccine Platforms: Looking Beyond the Pandemic and COVID-19

By |2022-10-04T16:37:24+00:00September 30th, 2022|Blog|

Over the last several months, it seems like we’ve been on a COVID-19 Rollercoaster. First, the long-awaited vaccines rolled out and a subsequent decline in cases was reported in regions where vaccines were rolled out quickly.

Comments Off on Vaccine Platforms: Looking Beyond the Pandemic and COVID-19

Eyam Acquires Option for Novel Antibody Biologic Therapeutics for the Treatment of Leukemia and Lymphoma

By |2022-10-07T16:04:15+00:00September 27th, 2022|News|

Over the last several months, it seems like we’ve been on a COVID-19 Rollercoaster. First, the long-awaited vaccines rolled out and a subsequent decline in cases was reported in regions where vaccines were rolled out quickly.

Comments Off on Eyam Acquires Option for Novel Antibody Biologic Therapeutics for the Treatment of Leukemia and Lymphoma

Pandemic Déjà vu?

By |2022-10-04T16:15:07+00:00August 31st, 2022|Blog|

Over the last several months, it seems like we’ve been on a COVID-19 Rollercoaster. First, the long-awaited vaccines rolled out and a subsequent decline in cases was reported in regions where vaccines were rolled out quickly.

Comments Off on Pandemic Déjà vu?

Eyam Vaccines And Immunotherapeutics Embarks On New Licensing Agreement For Creating Innovative Vaccine Technologies

By |2022-10-04T16:16:21+00:00August 3rd, 2022|News|

Over the last several months, it seems like we’ve been on a COVID-19 Rollercoaster. First, the long-awaited vaccines rolled out and a subsequent decline in cases was reported in regions where vaccines were rolled out quickly.

Comments Off on Eyam Vaccines And Immunotherapeutics Embarks On New Licensing Agreement For Creating Innovative Vaccine Technologies

Monkeypox and Vaccines

By |2022-08-03T16:38:06+00:00July 31st, 2022|Blog|

Over the last several months, it seems like we’ve been on a COVID-19 Rollercoaster. First, the long-awaited vaccines rolled out and a subsequent decline in cases was reported in regions where vaccines were rolled out quickly.

Comments Off on Monkeypox and Vaccines

Eyam’s Chief Scientific Officer, Dr. Wilfred Jefferies, Inducted in the National Academy of Inventors

By |2022-06-15T22:21:33+00:00June 15th, 2022|News|

Over the last several months, it seems like we’ve been on a COVID-19 Rollercoaster. First, the long-awaited vaccines rolled out and a subsequent decline in cases was reported in regions where vaccines were rolled out quickly.

Comments Off on Eyam’s Chief Scientific Officer, Dr. Wilfred Jefferies, Inducted in the National Academy of Inventors
Go to Top